Ascent Solar CIGS Modules Achieves Significant Efficiency Milestone

Ascent Solar Technologies, Inc. (NASDAQ:ASTI), a developer of state of the art flexible thin-film solar modules, today announced that it has achieved greater than 9.5% efficiency for its flexible Copper, Indium, Gallium, Selenide (CIGS) monolithically integrated modules.

The U.S. Department of Energy’s National Renewable Energy Laboratory (NREL) has independently verified that the modules measured as high as 9.64% in conversion efficiency. The modules tested at NREL were produced from the company’s 1.5MW pilot production line.

“We have been working to achieve these efficiencies during our internal optimization process, and we view this achievement as a tremendous breakthrough. The test modules measure six inches wide by one foot long and serves as our building block for portable power and building integrated photovoltaic (BIPV) products,” said Dr. Prem Nath, Sr. Vice President of Manufacturing for Ascent Solar. “Our goal continues to be the commercialization of flexible thin-film CIGS modules using a plastic substrate, which we hope will uniquely position Ascent Solar to provide light weight flexible photovoltaic material at low cost.”

Lawrence Kazmerksi, Executive Director at NREL, said, “This is significant. Many doubted that a thin-film CIGS solar cell-on-plastic technology could be possible. Ascent Solar not only achieved this, but they now have confirmed efficiencies at NREL on fully integrated, monolithic prototype modules near 10%. This appears to be a substantial leap toward realizing high-performance, inexpensive thin-film solar photovoltaics.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.